» Articles » PMID: 34532322

MiR-4732-3p in Extracellular Vesicles From Mesenchymal Stromal Cells Is Cardioprotective During Myocardial Ischemia

Abstract

Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) are an emerging alternative to cell-based therapies to treat many diseases. However, the complexity of producing homogeneous populations of EVs in sufficient amount hampers their clinical use. To address these limitations, we immortalized dental pulp-derived MSC using a human telomerase lentiviral vector and investigated the cardioprotective potential of a hypoxia-regulated EV-derived cargo microRNA, miR-4732-3p. We tested the compared the capacity of a synthetic miR-4732-3p mimic with EVs to confer protection to cardiomyocytes, fibroblasts and endothelial cells against oxygen-glucose deprivation (OGD). Results showed that OGD-induced cardiomyocytes treated with either EVs or miR-4732-3p showed prolonged spontaneous beating, lowered ROS levels, and less apoptosis. Transfection of the miR-4732-3p mimic was more effective than EVs in stimulating angiogenesis and and in reducing fibroblast differentiation upon transforming growth factor beta treatment. Finally, the miR-4732-3p mimic reduced scar tissue and preserved cardiac function when transplanted intramyocardially in infarcted nude rats. Overall, these results indicate that miR-4732-3p is regulated by hypoxia and exerts cardioprotective actions against ischemic insult, with potential application in cell-free-based therapeutic strategies.

Citing Articles

Mesenchymal stem cell-derived extracellular vesicles for cell-free therapy of ocular diseases.

Liu X, Hu L, Liu F Extracell Vesicles Circ Nucl Acids. 2024; 3(2):102-117.

PMID: 39698446 PMC: 11648472. DOI: 10.20517/evcna.2022.08.


Cell-based and extracellular vesicle-based MSC therapies for acute radiation syndrome affecting organ systems.

Miura Y, Fujii S, Ichinohe T J Radiat Res. 2024; 65(Supplement_1):i80-i87.

PMID: 39679884 PMC: 11647929. DOI: 10.1093/jrr/rrae009.


Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury.

Zhou W, Jiang X, Gao J Asian J Pharm Sci. 2024; 19(6):100965.

PMID: 39640057 PMC: 11617990. DOI: 10.1016/j.ajps.2024.100965.


Transforming Cardiotoxicity Detection in Cancer Therapies: The Promise of MicroRNAs as Precision Biomarkers.

Moscoso I, Rodriguez-Manero M, Cebro-Marquez M, Vilar-Sanchez M, Serrano-Cruz V, Vidal-Abeijon I Int J Mol Sci. 2024; 25(22).

PMID: 39595980 PMC: 11593668. DOI: 10.3390/ijms252211910.


Extracellular vesicles from dental pulp mesenchymal stem cells modulate macrophage phenotype during acute and chronic cardiac inflammation in athymic nude rats with myocardial infarction.

Amaro-Prellezo E, Gomez-Ferrer M, Hakobyan L, Ontoria-Oviedo I, Peiro-Molina E, Tarazona S Inflamm Regen. 2024; 44(1):25.

PMID: 38807194 PMC: 11134765. DOI: 10.1186/s41232-024-00340-7.


References
1.
Forsberg M, Kink J, Hematti P, Capitini C . Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol. 2020; 8:665. PMC: 7379234. DOI: 10.3389/fcell.2020.00665. View

2.
Gnecchi M, He H, Liang O, Melo L, Morello F, Mu H . Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005; 11(4):367-8. DOI: 10.1038/nm0405-367. View

3.
Litwin S, Katz S, Morgan J, Douglas P . Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation. 1994; 89(1):345-54. DOI: 10.1161/01.cir.89.1.345. View

4.
Lai R, Arslan F, Lee M, Sze N, Choo A, Chen T . Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010; 4(3):214-22. DOI: 10.1016/j.scr.2009.12.003. View

5.
Fan Z, Qu X, Chu P, Gao Y, Gao X, Chen S . MicroRNA-210 promotes angiogenesis in acute myocardial infarction. Mol Med Rep. 2018; 17(4):5658-5665. PMC: 5866007. DOI: 10.3892/mmr.2018.8620. View